Navigation Links
Chiltern Expands European Operations With a New Office in Belgium
Date:6/17/2009

LONDON, June 17 /PRNewswire/ -- Chiltern, a leading global clinical research organization, announced that it has opened a new office in Brussels and is pleased to have appointed Mr. Maurizio Passinisi as our new country manager for Belgium and The Netherlands.

Mr. Maurizio Passanisi received a Master of Science degree in Industrial Engineering from the Institut Superieur Industriel Liegeois of Liege (ISIL) in 1993 and a Master of Science degree in Management from Haute Ecole Commerciale (HEC) - University of Liege in 2008. Mr. Passanisi has over 15 years of experience working in both Pharmaceutical and Clinical Research areas.

"Belgium and The Netherlands have always been attractive locations to conduct clinical trials," Maurizio commented. "The quality of the research is outstanding. Belgium and The Netherlands have many key opinion leaders (KOL) involved in clinical research lending additional weight to the data and keeping these countries at the forefront of modern research."

"Chiltern is experiencing healthy growth despite the current economic climate," explained Lewis Cameron, Executive Vice President for Europe. "Chiltern is continuing its growth in Europe and will shortly announce further expansion in Eastern Europe. Our primary goal is to deliver expert, high quality services around the world and these actions demonstrate our commitment to regional expansion in order to serve our clients needs globally."

Company profile

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern has conducted trials in more than 40 countries and employs 1400 staff across 29 countries. Chiltern provides services including Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Further information is available at www.chiltern.com.

    For More Information Contact:

    Stuart McGuire                            Mac McElroy
    Chiltern International Ltd.               Chiltern International Inc.
    171 Bath Road                             1241 Volunteer Parkway
    Slough                                    Suite 950
    Berkshire SL1 4AA                         Bristol, TN 37620
    UNITED KINGDOM                            USA
    Tel:  +44 (0) 1753 512 000                Tel:  +1 (423) 968 9533
    Fax: +44 (0) 1753 511 116                 Fax: +1 (423) 968 3567
    Email: stuart.mcguire@chiltern.com        Email: mac.mcelroy@chiltern.com


'/>"/>
SOURCE Chiltern International Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Marco Romano, MD Joins Chiltern as Medical Director, Europe
2. Chiltern Appoints Steve Albrecht to Support Further Expansion in Late Phase
3. Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc.
4. Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam
5. Diana Hatsis of Chiltern Will Present at the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) 35th Annual Continuing Education Program Held in Conjunction With the American Academy of Ophthalmology (AAO) Annual Meeting
6. Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS)
7. Chiltern Wins Top Prize
8. Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas, April 14 - 16, 2008.
9. Chiltern Opens a New Office in Russia
10. Chiltern Announces New Expansion in Portugal
11. Chiltern Expands Its Global Reach to Latin America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... (PRWEB) , ... February 28, 2017 , ... ... Coach Institute (HCI) announced a new partnership through which HCI students, faculty, ... coaching curriculum and practices. The partnership also enables the HCI community to receive ...
(Date:2/28/2017)... (PRWEB) , ... February 28, 2017 , ... ... Overl.ai Inc., a healthcare automation intelligence company based in New York. , “Ensuring ... ensuring the provider’s workflow remains unaltered. Those two fundamental reasons are the reasons ...
(Date:2/27/2017)... ... ... Bo Chen, PhD is the recipient of the 2017 ASLMS Dr. Horace ... Session at ASLMS 2017, the Annual Conference of the American Society for Laser Medicine ... , During the Plenary Session on April 7, Dr. Chen will give his ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... Healing and Spiritual Awakening, is happy to announce her “Spring Rejuvenation in ... body, these individual customized retreats offer the winter-weary soul an excellent opportunity to ...
(Date:2/27/2017)... ... February 27, 2017 , ... Orange County dentist, Dr. A. Rassouli, ... that occurs when the bacteria in plaque infect the gums and other tissues supporting ... and root planing or SRP, and can include surgical therapies if the condition has ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... DUBLIN , Feb 28, 2017 ... "Digestive Enzyme Supplements Market Forecasts 2014-2025" report to their ... ... reach USD 1.6 billion by 2025. Growing consumer awareness regarding ... good health is expected to stimulate industry growth over the ...
(Date:2/27/2017)... 27, 2017 Halyard Health, Inc. (NYSE: ... and provided its 2017 outlook and related key planning assumptions. ... $410 million, a 2 percent increase compared to the prior ... 2016 was $10 million compared to net income of $15 ... net income was $24 million compared to adjusted net income ...
(Date:2/27/2017)... 27, 2017   Royal Philips (NYSE: ... leader in health technology, today announced 510(k) clearance ... to market its ElastQ Imaging capability, further expanding ... systems. ElastQ Imaging enables simultaneous imaging of tissue ... for the diagnosis of various liver conditions. With ...
Breaking Medicine Technology: